MIR544B

Across TCGA pan-cancer cohorts, MIR544B RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of MIR544B’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR544B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR544B is over-expressed in tumor, although a few such as COAD and KIRC show the opposite, repressed pattern.

BLCA, STAD, and KIRP are the cancer types where MIR544B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR544B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	All	+0.625	.009	8	view →
STAD	All	II,III,IV	+0.526	<.001	8	view →
KIRP	Female	II,III,IV	+0.718	.016	4	view →
COAD	Male	II,III,IV	−0.465	.005	4	view →
BRCA	All	All	+0.287	.008	4	view →
HNSC	All	II,III,IV	+0.204	.007	4	view →
LUSC	All	All	+0.415	.001	3	view →
KIRC	All	III,IV	−0.125	.037	3	view →
UCEC	All	IV	+1.250	.020	2	view →
CHOL	All	II,III,IV	+1.225	.046	2	view →
LUAD	All	All	+0.361	.010	2	view →
THCA	Male	II,III,IV	−0.424	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

MIR544B–BLCA

Open the BLCA breakdown →